Claudio Gobbi - Concepedia

Author

Claudio Gobbi

Università della Svizzera italiana ORCID

Also Known As

Britta Engelhardt, C Gobbi, C. GOBBI, C. Gobbi, C.G. Claudio Gobbi, C.G. Gobbi, Cecilia Gobbi, Celeste Gobbi, Claudio Gobbi, Cristina Ramo-Tello

291

Publications

7.7K

Citations

H-Index

109

Concepts

All Affiliations

Università della Svizzera italiana Ospedale regionale di Lugano Laboratory for Biomedical Neurosciences University Hospital of Basel University of Basel

About

Claudio Gobbi is an author at Università della Svizzera italiana specializing in medicine, neurology, and neuropathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1.9K
2	Health Sciences	6	6	1.5K
3	Nursing	3	3	48
4	Education	1	1	47
5	Engineering	1	1	15

Claudio Gobbi

104

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis Giulio Disanto, Christian Barro, Pascal Benkert, Annals of Neurology	2017	1.1K
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study Ludwig Kappos, Amit Bar‐Or, Bruce Cree, The Lancet Neurological DisorderClinical NeurologyClinical TrialsSiponimod Versus PlaceboNeurological Monitoring	2018	896
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis Christian Barro, Pascal Benkert, Giulio Disanto, Brain Neurological DisorderNeuro-axonal InjuryNeurological FunctioningNeurobiology Of DiseaseSerum Neurofilament	2018	516
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis Stéphanie Meier, Eline A.J. Willemse, Sabine Schaedelin, JAMA Neurology	2023	230
Prodromal symptoms of multiple sclerosis in primary care Giulio Disanto, Chiara Zecca, Sharon MacLachlan, Annals of Neurology	2018	159
Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis Alessandro Cagol, Sabine Schaedelin, Muhamed Baraković, JAMA Neurology	2022	156
The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most? Laura Barin, Anke Salmen, Giulio Disanto, Multiple Sclerosis and Related Disorders Systemic DiseasesDisease ProgressionDisease BurdenMedicineNeuroepidemiology	2018	137
Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis Claudio Gobbi, Maria A. Rocca, Gianna Carla Riccitelli, Multiple Sclerosis Journal	2013	115
Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis Giulio Disanto, Rosaria Sacco, Enos Bernasconi, JAMA Neurology	2021	112
Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial Claudio Gobbi, GA Digesu, V. Khullar, Multiple Sclerosis Journal	2011	92

Page 1